Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Zupancic

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|August 25, 2023
Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregatesJennifer M Zupancic, Matthew D Smith, Hanna Trzeciakiewicz, et al.
Nature Communications|July 1, 2022
Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational spaceEmily K Makowski, Patrick C Kinnunen, Jie Huang, et al.
Cell Chemical Biology|June 25, 2021
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, John S Schardt, et al.
Mabs|November 26, 2022
Reduction of therapeutic antibody self-association using yeast-display selections and machine learningEmily K Makowski, Hongwei Chen, Matthew Lambert, et al.
Scientific Reports|October 21, 2021
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screeningJohn S Schardt, Ghasidit Pornnoppadol, Alec A Desai, et al.
Frontiers in Immunology|October 29, 2025
Directed evolution of drug-like Aβ conformation-specific antibodiesAlec A Desai, Matthew D Smith, Jennifer M Zupancic, et al.
Biotechnology Progress|April 3, 2024
Development of a pan-tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregatesNikki McArthur, Bokyung Kang, Felix G Rivera Moctezuma, et al.
The Journal of Biological Chemistry|March 6, 2021
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificityAlec A Desai, Matthew D Smith, Yulei Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrilsAlec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, et al.
Nature Chemical Biology|April 29, 2025
Facile generation of drug-like conformational antibodies specific for amyloid fibrilsAlec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|August 25, 2023
Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregatesJennifer M Zupancic, Matthew D Smith, Hanna Trzeciakiewicz, et al.
Nature Communications|July 1, 2022
Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational spaceEmily K Makowski, Patrick C Kinnunen, Jie Huang, et al.
Cell Chemical Biology|June 25, 2021
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, John S Schardt, et al.
Mabs|November 26, 2022
Reduction of therapeutic antibody self-association using yeast-display selections and machine learningEmily K Makowski, Hongwei Chen, Matthew Lambert, et al.
Scientific Reports|October 21, 2021
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screeningJohn S Schardt, Ghasidit Pornnoppadol, Alec A Desai, et al.
Frontiers in Immunology|October 29, 2025
Directed evolution of drug-like Aβ conformation-specific antibodiesAlec A Desai, Matthew D Smith, Jennifer M Zupancic, et al.
Biotechnology Progress|April 3, 2024
Development of a pan-tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregatesNikki McArthur, Bokyung Kang, Felix G Rivera Moctezuma, et al.
The Journal of Biological Chemistry|March 6, 2021
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificityAlec A Desai, Matthew D Smith, Yulei Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrilsAlec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, et al.
Nature Chemical Biology|April 29, 2025
Facile generation of drug-like conformational antibodies specific for amyloid fibrilsAlec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz, et al.
Pageof 2